Learn about the program
Apply for LSDP-funded treatment
Our expert panel
Apply to list a new medicine
Browse the Life Saving Drugs Program for
Patients
Find out how to get medicines through the program and what your responsibilities are.
Treating physicians
See how to start patients on LSDP medicines, comply with program requirements, and make any required changes over time.
Pharmacists
Find out how to become an LSDP pharmacy, manage LSDP medicines correctly, prevent wastage, and keep us informed.
Medicine sponsors
Read the medicines eligibility criteria and find out how to list a medicine on the LSDP.
Soliris® (eculizumab) available on PBS from 1 March 2022
The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).